John D. Hoekman,Kelsey H. Satterly,Inna Dashevsky,Aditya R. Das,Stephen B. Shrewsbury,Gregory J. Davies,Bhavin Y. Gajera
申请号：
US16517423
公开号：
US20200046667A1
申请日:
2019.07.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A dry pharmaceutical composition is provided that is suitable for respiratory tract delivery of levodopa and DDI for treatment of Parkinson's disease or Parkinson syndrome. The dry pharmaceutical composition comprises levodopa, a dopa decarboxylase inhibitor (DDI) and at least one excipient. A unit dosage form of the dry pharmaceutical composition and a method of treating a patient with Parkinson's disease or Parkinson syndrome by administering the dry pharmaceutical composition are also provided.
